The potential effects of Cytotoxic T lymphocyte antigen 4 -Ig on human B cell response
碩士 === 國立陽明大學 === 微生物及免疫學研究所 === 105 === Abatacept is a cytotoxic T lymphocyte antigen-4 (CTLA-4) fusion protein approved for rheumatoid arthritis (RA) treatment worldwide. Abatacept is able to mimic the natural CTLA-4 and compete CD28 binding their ligands CD80/CD86 to prevent T cell activation. Ho...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2017
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/3re6s7 |